Oragenics Inc (OGEN) Stock Analysis

Oragenics Inc (OGEN) is a publicly traded company in the HEALTHCARE sector. It trades at $0.62, carries a market capitalization of $2.73M. This page summarizes the public market data, fundamentals, and frequently asked questions for OGEN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

Market Sentiment

Oragenics Inc currently has a Bullish sentiment score of 0.53.

About Oragenics Inc

Oragenics, Inc. is a biotechnology company based in Tampa, Florida, focused on the development of innovative antibiotics and therapies for infectious diseases, including those caused by antibiotic-resistant bacteria. The company is actively pursuing novel drug candidates that leverage its proprietary technologies to address critical healthcare challenges. With a commitment to advancing healthcare solutions, Oragenics aims to contribute significantly to the global fight against infections, tar...

GNG Research Analysis

GNG Research scores Oragenics Inc (OGEN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OGEN.

Frequently Asked Questions

Does OGEN pay dividends?

Oragenics Inc (OGEN) does not currently pay a regular dividend.

What is OGEN's market cap?

Oragenics Inc (OGEN) has a market capitalization of $2.73M with a current stock price of $0.62.